CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Effect of Ocoxin-Viusid® Nutritional Supplement in the Life Quality in Patients Diagnosed With Advanced Pancreatic Adenocarcinoma. Phase II

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03717298
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:15.128977+00:00
Published At: 2023-03-28T00:00:00+00:00
Record Updated At: 2023-03-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adenocarcinoma of the Pancreas", "Pancreatic Cancer", "Advanced Cancer", "Digestive System Neoplasms", "Pancreatic Neoplasms", "Endocrine Gland Neoplasms", "Digestive System Diseases", "Endocrine System Diseases", "Pancreatic Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-03-28"
protocolSection.identificationModule.nctId: "NCT03717298"
protocolSection.identificationModule.officialTitle: "Evaluation of the Effect of Ocoxin-Viusid\u00ae Nutritional Supplement in the Life Quality in Patients Diagnosed With Advanced Pancreatic Adenocarcinoma. Phase II"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.